The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
Open accessAbstract
BACKGROUND Endovascular treatment for anterior circulation ischaemic stroke is effective and safe within a 6 h window. MR CLEAN-LATE aimed to assess efficacy and safety of endovascular treatment for patients treated in the late window (6-24 h from symptom onset or last seen well) selected on the basis of the presence of collateral flow on CT angiography (CTA). METHODS MR CLEAN-LATE was a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial done in 18 stroke intervention centres in the Netherlands. Patients aged 18 years or older with ischaemic stroke, presenting in the late window with an anterior circulation large-vessel occlusion and collateral flow on CTA, and a neurological deficit score of at least 2 on the National Institutes of Health Stroke Scale were included. Patients who were eligible for late-window endovascular treatment were treated according to national guidelines (based on clinical and perfusion imaging criteria derived from the DAWN and DEFUSE-3 trials) and excluded from MR CLEAN-LATE enrolment. Patients were randomly assigned (1:1) to receive endovascular treatment or no endovascular treatment (control), in addition to best medical treatment. Randomisation was web based, with block sizes ranging from eight to 20, and stratified by centre. The primary outcome was the modified Rankin Scale (mRS) score at 90 days after randomisation. Safety outcomes included all-cause mortality at 90 days after randomisation and symptomatic intracranial haemorrhage. All randomly assigned patients who provided deferred consent or died before consent could be obtained comprised the modified intention-to-treat population, in which the primary and safety outcomes were assessed. Analyses were adjusted for predefined confounders. Treatment effect was estimated with ordinal logistic regression and reported as an adjusted common odds ratio (OR) with a 95% CI. This trial was registered with the ISRCTN, ISRCTN19922220. FINDINGS Between Feb 2, 2018, and Jan 27, 2022, 535 patients were randomly assigned, and 502 (94%) patients provided deferred consent or died before consent was obtained (255 in the endovascular treatment group and 247 in the control group; 261 [52%] females). The median mRS score at 90 days was lower in the endovascular treatment group than in the control group (3 [IQR 2-5] vs 4 [2-6]), and we observed a shift towards better outcomes on the mRS for the endovascular treatment group (adjusted common OR 1·67 [95% CI 1·20-2·32]). All-cause mortality did not differ significantly between groups (62 [24%] of 255 patients vs 74 [30%] of 247 patients; adjusted OR 0·72 [95% CI 0·44-1·18]). Symptomatic intracranial haemorrhage occurred more often in the endovascular treatment group than in the control group (17 [7%] vs four [2%]; adjusted OR 4·59 [95% CI 1·49-14·10]). INTERPRETATION In this study, endovascular treatment was efficacious and safe for patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion who presented 6-24 h from onset or last seen well, and who were selected on the basis of the presence of collateral flow on CTA. Selection of patients for endovascular treatment in the late window could be primarily based on the presence of collateral flow. FUNDING Collaboration for New Treatments of Acute Stroke consortium, Dutch Heart Foundation, Stryker, Medtronic, Cerenovus, Top Sector Life Sciences & Health, and the Netherlands Brain Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Self-citationA Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,657
Self-citationInterobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Goyal, M., Demchuk, A. M., Menon, B. K., Eesa, M., Rempel, J. L., Thornton, J., Roy, D., Jovin, T. G., Willinsky, R. A., Sapkota, B. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414905 · Cited by 6,083
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
Nogueira, R. G., Jadhav, A. P., Haussen, D. C., Bonafe, A., Budzik, R. F., Bhuva, P., Yavagal, D. R., Ribo, M., Cognard, C., Hanel, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706442 · Cited by 5,629
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Albers, G. W., Marks, M. P., Kemp, S., Christensen, S., Tsai, J. P., Ortega-Gutierrez, S., McTaggart, R. A., Torbey, M. T., Kim-Tenser, M., Leslie-Mazwi, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713973 · Cited by 4,930
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
Jovin, T. G., Chamorro, A., Cobo, E., de Miquel, M. A., Molina, C. A., Rovira, A., San Román, L., Serena, J., Abilleira, S., Ribó, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503780 · Cited by 4,898
Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Saver, J. L., Goyal, M., van der Lugt, A., Menon, B. K., Majoie, C. B. L. M., Dippel, D. W., Campbell, B. C., Nogueira, R. G., Demchuk, A. M., Tomasello, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.13647 · Cited by 2,180
Self-citationvon Kummer, R., Broderick, J. P., Campbell, B. C. V., Demchuk, A., Goyal, M., Hill, M. D., Treurniet, K. M., Majoie, C. B. L. M., Marquering, H. A., Mazya, M. V., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010049 · Cited by 1,409
Self-citationDo Clinicians Overestimate the Severity of Intracerebral Hemorrhage?
Tilling, E. J., El Tawil, S., & Muir, K. W. (2019) · Stroke · doi:10.1161/strokeaha.118.022606 · Cited by 1,120
Endovascular Therapy for Acute Stroke with a Large Ischemic Region
Yoshimura, S., Sakai, N., Yamagami, H., Uchida, K., Beppu, M., Toyoda, K., Matsumaru, Y., Matsumoto, Y., Kimura, K., Takeuchi, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118191 · Cited by 873
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Tan, I. Y. L., Demchuk, A. M., Hopyan, J., Zhang, L., Gladstone, D., Wong, K., Martin, M., Symons, S. P., Fox, A. J., & Aviv, R. I. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1408 · Cited by 735
Systematic comparison of perfusion‐CT and CT‐angiography in acute stroke patients
Tan, J. C., Dillon, W. P., Liu, S., Adler, F., Smith, W. S., & Wintermark, M. (2007) · Annals of Neurology · doi:10.1002/ana.21130 · Cited by 394
Rocha, M., & Jovin, T. G. (2017) · Stroke · doi:10.1161/strokeaha.117.017673 · Cited by 319
Berkhemer, O. A., Jansen, I. G. H., Beumer, D., Fransen, P. S. S., van den Berg, L. A., Yoo, A. J., Lingsma, H. F., Sprengers, M. E. S., Jenniskens, S. F. M., Lycklama à Nijeholt, G. J., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011788 · Cited by 285
Self-citationNguyen, T. N., Abdalkader, M., Nagel, S., Qureshi, M. M., Ribo, M., Caparros, F., Haussen, D. C., Mohammaden, M. H., Sheth, S. A., Ortega-Gutierrez, S., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.4082 · Cited by 277
Thrombectomy for Stroke in the Public Health Care System of Brazil
Martins, S. O., Mont’Alverne, F., Rebello, L. C., Abud, D. G., Silva, G. S., Lima, F. O., Parente, B. S. M., Nakiri, G. S., Faria, M. B., Frudit, M. E., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2000120 · Cited by 232
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial
Liebeskind, D. S., Saber, H., Xiang, B., Jadhav, A. P., Jovin, T. G., Haussen, D. C., Budzik, R. F., Bonafé, A., Bhuva, P., Yavagal, D. R., et al. (2021) · Stroke · doi:10.1161/strokeaha.121.034471 · Cited by 144
de Havenon, A., Mlynash, M., Kim‐Tenser, M. A., Lansberg, M. G., Leslie-Mazwi, T., Christensen, S., McTaggart, R., Alexander, M. D., Albers, G. W., Broderick, J. P., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023407 · Cited by 132
Hernández, A. V., Steyerberg, E. W., Butcher, I., Mushkudiani, N. A., Taylor, G. S., Murray, G. D., Marmarou, A., Choi, S. C., Lü, J., Habbema, J. D. F., et al. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1295 · Cited by 82
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke
Kim, Y., Lee, S., Abdelkhaleq, R., Lopez‐Rivera, V., Navi, B. B., Kamel, H., Savitz, S. I., Czap, A. L., Grotta, J. C., McCullough, L. D., et al. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006989 · Cited by 74
Nguyen, T. N., Klein, P., Berberich, A., Nagel, S., Abdalkader, M. K., Herning, A., Chen, Y., Huo, X., Miao, Z., Sheth, S. A., et al. (2022) · Stroke Vascular and Interventional Neurology · doi:10.1161/svin.122.000595 · Cited by 42
Self-citation
Cited by
Hilkens, N. A., Casolla, B., Leung, T. W., & de Leeuw, F.-E. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00642-1 · Cited by 681
Metadata
- Authors
- Olthuis, S. G. H., Pirson, F. A. V., Pinckaers, F. M. E., Hinsenveld, W. H., Nieboer, D., Ceulemans, A., Knapen, R. R. M. M., Robbe, M. M. Q., Berkhemer, O. A., van Walderveen, M. A. A., Lycklama à Nijeholt, G. J., Uyttenboogaart, M., Schonewille, W. J., van der Sluijs, P. M., Wolff, L., van Voorst, H., Postma, A. A., Roosendaal, S. D., van der Hoorn, A., Emmer, B. J., Krietemeijer, M. G. M., van Doormaal, P.-J., Roozenbeek, B., Goldhoorn, R.-J. B., Staals, J., de Ridder, I. R., van der Leij, C., Coutinho, J. M., van der Worp, H. B., Lo, R. T. H., Bokkers, R. P. H., van Dijk, E. I., Boogaarts, H. D., Wermer, M. J. H., van Es, A. C. G. M., van Tuijl, J. H., Kortman, H. G. J., Gons, R. A. R., Yo, L. S. F., Vos, J.-A., de Laat, K. F., van Dijk, L. C., van den Wijngaard, I. R., Hofmeijer, J., Martens, J. M., Brouwers, P. J. A. M., Bulut, T., Remmers, M. J. M., de Jong, T. E. A. M., den Hertog, H. M., van Hasselt, B. A. A. M., Rozeman, A. D., Elgersma, O. E. H., van der Veen, B., Sudiono, D. R., Lingsma, H. F., Roos, Y. B. W. E. M., Majoie, C. B. L. M., van der Lugt, A., Dippel, D. W. J., van Zwam, W. H., & van Oostenbrugge, R. J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 401
- Issue
- 10385
- Pages
- 1371-1380
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4361195665
- Cited by
- 259
- References
- 23
- FWCI
- 43.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.